These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 22407892)

  • 1. Ablation of both organic cation transporter (OCT)1 and OCT2 alters metformin pharmacokinetics but has no effect on tissue drug exposure and pharmacodynamics.
    Higgins JW; Bedwell DW; Zamek-Gliszczynski MJ
    Drug Metab Dispos; 2012 Jun; 40(6):1170-7. PubMed ID: 22407892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rifampin enhances the glucose-lowering effect of metformin and increases OCT1 mRNA levels in healthy participants.
    Cho SK; Yoon JS; Lee MG; Lee DH; Lim LA; Park K; Park MS; Chung JY
    Clin Pharmacol Ther; 2011 Mar; 89(3):416-21. PubMed ID: 21270793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin.
    Wang DS; Jonker JW; Kato Y; Kusuhara H; Schinkel AH; Sugiyama Y
    J Pharmacol Exp Ther; 2002 Aug; 302(2):510-5. PubMed ID: 12130709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional characterization of the human organic cation transporter 2 variant p.270Ala>Ser.
    Zolk O; Solbach TF; König J; Fromm MF
    Drug Metab Dispos; 2009 Jun; 37(6):1312-8. PubMed ID: 19251820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin is a superior substrate for renal organic cation transporter OCT2 rather than hepatic OCT1.
    Kimura N; Masuda S; Tanihara Y; Ueo H; Okuda M; Katsura T; Inui K
    Drug Metab Pharmacokinet; 2005 Oct; 20(5):379-86. PubMed ID: 16272756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elucidation of
    Miyake T; Mizuno T; Takehara I; Mochizuki T; Kimura M; Matsuki S; Irie S; Watanabe N; Kato Y; Ieiri I; Maeda K; Ando O; Kusuhara H
    Drug Metab Dispos; 2019 Nov; 47(11):1270-1280. PubMed ID: 31511257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of clinical drug-drug interactions of veliparib (ABT-888) with human renal transporters (OAT1, OAT3, OCT2, MATE1, and MATE2K).
    Kikuchi R; Lao Y; Bow DA; Chiou WJ; Andracki ME; Carr RA; Voorman RL; De Morais SM
    J Pharm Sci; 2013 Dec; 102(12):4426-32. PubMed ID: 24122511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted disruption of the multidrug and toxin extrusion 1 (mate1) gene in mice reduces renal secretion of metformin.
    Tsuda M; Terada T; Mizuno T; Katsura T; Shimakura J; Inui K
    Mol Pharmacol; 2009 Jun; 75(6):1280-6. PubMed ID: 19332510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of Oct1/Oct2-deficiency on cisplatin-induced changes in urinary N-acetyl-beta-D-glucosaminidase.
    Franke RM; Kosloske AM; Lancaster CS; Filipski KK; Hu C; Zolk O; Mathijssen RH; Sparreboom A
    Clin Cancer Res; 2010 Aug; 16(16):4198-206. PubMed ID: 20601443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of Altered Metformin Distribution in Nonalcoholic Steatohepatitis.
    Clarke JD; Dzierlenga AL; Nelson NR; Li H; Werts S; Goedken MJ; Cherrington NJ
    Diabetes; 2015 Sep; 64(9):3305-13. PubMed ID: 26016715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characteristics and steroid hormone-mediated regulation of an organic cation transporter in Madin-Darby canine kidney cells.
    Shu Y; Bello CL; Mangravite LM; Feng B; Giacomini KM
    J Pharmacol Exp Ther; 2001 Oct; 299(1):392-8. PubMed ID: 11561104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted disruption of organic cation transporter 3 attenuates the pharmacologic response to metformin.
    Chen EC; Liang X; Yee SW; Geier EG; Stocker SL; Chen L; Giacomini KM
    Mol Pharmacol; 2015 Jul; 88(1):75-83. PubMed ID: 25920679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organic cation transporter-mediated drug-drug interaction potential between berberine and metformin.
    Kwon M; Choi YA; Choi MK; Song IS
    Arch Pharm Res; 2015; 38(5):849-56. PubMed ID: 25359200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular localization of the organic cation transporters, OCT1 and OCT2, in brain microvessel endothelial cells and its implication for MPTP transport across the blood-brain barrier and MPTP-induced dopaminergic toxicity in rodents.
    Lin CJ; Tai Y; Huang MT; Tsai YF; Hsu HJ; Tzen KY; Liou HH
    J Neurochem; 2010 Aug; 114(3):717-27. PubMed ID: 20477935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of genetic polymorphisms in the organic cation transporters OCT1, OCT2, and OCT3 on the renal clearance of metformin.
    Tzvetkov MV; Vormfelde SV; Balen D; Meineke I; Schmidt T; Sehrt D; Sabolić I; Koepsell H; Brockmöller J
    Clin Pharmacol Ther; 2009 Sep; 86(3):299-306. PubMed ID: 19536068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics.
    Shu Y; Brown C; Castro RA; Shi RJ; Lin ET; Owen RP; Sheardown SA; Yue L; Burchard EG; Brett CM; Giacomini KM
    Clin Pharmacol Ther; 2008 Feb; 83(2):273-80. PubMed ID: 17609683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficiency in the organic cation transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in mice abolishes renal secretion of organic cations.
    Jonker JW; Wagenaar E; Van Eijl S; Schinkel AH
    Mol Cell Biol; 2003 Nov; 23(21):7902-8. PubMed ID: 14560032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical CYP3A inhibitor alternatives to ketoconazole, clarithromycin and itraconazole, are not transported into the liver by hepatic organic anion transporting polypeptides and organic cation transporter 1.
    Higgins JW; Ke AB; Zamek-Gliszczynski MJ
    Drug Metab Dispos; 2014 Nov; 42(11):1780-4. PubMed ID: 25106415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin and cimetidine: Physiologically based pharmacokinetic modelling to investigate transporter mediated drug-drug interactions.
    Burt HJ; Neuhoff S; Almond L; Gaohua L; Harwood MD; Jamei M; Rostami-Hodjegan A; Tucker GT; Rowland-Yeo K
    Eur J Pharm Sci; 2016 Jun; 88():70-82. PubMed ID: 27019345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of Organic Cation Transporter 1 (OCT1) Substrates in Oct1/2 Knockout Mice and Species Difference in Hepatic OCT1-Mediated Uptake.
    Morse BL; Kolur A; Hudson LR; Hogan AT; Chen LH; Brackman RM; Sawada GA; Fallon JK; Smith PC; Hillgren KM
    Drug Metab Dispos; 2020 Feb; 48(2):93-105. PubMed ID: 31771949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.